# Effects of cold-water immersion at different body regions on post-exercise muscle damage recovery: a systematic review and meta-analysis

**Authors:** Yang Zhu, Lele Yang, Tao Liu, Fuya Yao, Qilong Wang, Zheng Yi

PMC · DOI: 10.3389/fspor.2026.1738075 · Frontiers in Sports and Active Living · 2026-02-05

## TL;DR

This study finds that cold-water immersion helps reduce muscle damage and soreness after exercise, with whole-body and partial immersion being equally effective, though partial immersion may slightly hinder explosive power immediately.

## Contribution

The study confirms the equivalence of whole-body and partial cold-water immersion for recovery, suggesting partial immersion as the optimal strategy for next-day recovery.

## Key findings

- CWI significantly reduced creatine kinase levels and delayed onset muscle soreness.
- Whole-body and partial immersion showed no significant difference in recovery outcomes.
- Partial immersion slightly inhibited immediate explosive power recovery.

## Abstract

The aim of this study was to systematically evaluate the differences in efficacy of Cold-Water Immersion (CWI) applied to different body regions for post-exercise muscle damage recovery.

The PRISMA guidelines were followed. Databases including PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception to October 20, 2025. Randomized controlled trials (RCTs) comparing single acute CWI with seated passive rest were included. Methodological quality and risk of bias were assessed using the PEDro scale and RoB 2 tool, respectively. Data analysis was performed using Stata-MP 18.0 software.

Thirty RCTs were included, and the overall quality was high. The meta-analysis showed that CWI significantly reduced post-exercise CK levels (g = –0.24; 95% CI: −0.37 to −0.10, P < 0.01) and alleviated DOMS (g = –0.40; 95% CI: −0.64 to −0.16, P < 0.01) compared to the control group. However, no statistically significant benefits were observed for the recovery of CMJ (g = –0.02; 95% CI: −0.17 to 0.13, P > 0.05) or MVIC (g = 0.08; 95% CI: −0.08 to 0.23, P > 0.05). Subgroup analysis indicated no significant difference between whole-body and partial immersion at any follow-up time point (0–72 h) (between-group P > 0.05). Notably, a significant inhibitory effect on immediate (0 h) explosive power (CMJ) was shown by partial CWI (g = –0.94, P < 0.01). The primary biochemical and subjective benefits were concentrated at 24 h. Robustness of the main results was confirmed by sensitivity analysis, though potential publication bias was detected for CK.

Biochemical (CK) and subjective (DOMS) recovery were effectively improved by CWI. However, muscle strength (MVIC) was not synchronously enhanced, and explosive power (CMJ) was immediately inhibited. The equivalence of therapeutic efficacy between whole-body and partial immersion was confirmed as a core finding. Consequently, partial immersion is considered the optimal strategy combining efficacy and safety. It is suitable for accelerating next-day recovery. However, it should be used with caution during intervals involving continuous explosive power output.

PROSPERO CRD420251171826.

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** CWI (MESH:D007102), fatigue (MESH:D005221), CK (OMIM:300831), muscle damage (MESH:D009133), Inflammatory (MESH:D007249), CMJ (MESH:C000711648), muscle (MESH:D019042), pain (MESH:D010146), edema (MESH:D004487), musculoskeletal injury (MESH:D009140), DOMS (MESH:D063806), EIMD (MESH:D000092202), impairment of neuromuscular function (MESH:D009468), MVIC (MESH:D009155), muscle hypertrophy (MESH:C536106), hypertrophy (MESH:D006984)
- **Chemicals:** Water (MESH:D014867), norepinephrine (MESH:D009638), oxygen (MESH:D010100), prostaglandins (MESH:D011453), lactate (MESH:D019344), epinephrine (MESH:D004837), reactive oxygen species (MESH:D017382), calcium (MESH:D002118), CWI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916111/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916111/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916111/full.md

---
Source: https://tomesphere.com/paper/PMC12916111